SGI on NYSE
Tempur Sealy International
American company that manufactures mattresses
Somnigroup International Inc. is an American manufacturer of mattresses and bedding products.3 From Wikipedia, CC BY-SA 4.0
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Leggett & Platt, La-Z-Boy or Compass Diversified, or pick any stock.
- TickerSGI on NYSE1
- Industrybedding, mattress1
- HeadquartersLexington1
- Websitewww.tempursealy.com
- Legal formDelaware corporation1
- Incorporated inDE4
- Business address1000 Tempur Way, Lexington, Ky 405114
- Filer categoryLarge accelerated filer4
See how the biggest companies compare on our leaderboards
Somnigroup International Inc. is an American manufacturer of mattresses and bedding products.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Tempur Sealy North America brought in 44% of the revenue Tempur Sealy International broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Tempur Sealy North America | $3.9B | $3.8B | $3.7B |
| Mattress Firm | $3.5B | ||
| Tempur Sealy International | $1.1B | $1.1B | $1.3B |
Regions
United States brought in 79% of the revenue Tempur Sealy International broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $3.6B | $3.5B | $5.9B |
| Outside the United States | $1.4B | $1.4B | $1.5B |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue57¢$4.3B
- Research and development0¢$32.9M
- Other costs36¢$2.7B
- Income tax1¢$95.7M
- Profit5¢$384.1M
Out of $7.5B in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending21¢$166.9M
- Dividends paid16¢$127.4M
- Kept or used elsewhere63¢$505.8M
Out of $800.1M of cash from operations.5
Financial statements
Every line of the income statement in the latest annual report, as filed.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $7.5B | $4.9B | $4.9B |
| Cost of sales | $4.3B | $2.9B | $2.9B |
| Gross profit | $3.2B | $2.0B | $2.0B |
| Selling and marketing expenses | $1.7B | $939.4M | $920.9M |
| General, administrative and other expenses | $695.0M | $473.2M | $481.1M |
| Loss on disposal of business | $13.9M | $0 | $0 |
| Equity income in earnings of unconsolidated affiliates | -$19.6M | -$18.9M | -$23.0M |
| Operating income | $754.9M | $634.2M | $607.2M |
| Interest expense, net | $267.9M | $134.8M | $129.9M |
| Loss on extinguishment of debt | $0 | $0 | $3.2M |
| Other expense (income), net | $6.0M | -$4.9M | $0 |
| Total other expense, net | $273.9M | $129.9M | $133.1M |
| Income before income taxes | $481.0M | $504.3M | $474.1M |
| Income tax provision | -$95.7M | -$118.6M | -$103.4M |
| Net income before non-controlling interest | $385.3M | $385.7M | $370.7M |
| Less: Net income attributable to non-controlling interest | $1.2M | $1.4M | $2.6M |
| Net income attributable to Somnigroup International Inc. | $384.1M | $384.3M | $368.1M |
| Basic (in dollars per share) | $1.86 | $2.21 | $2.14 |
| Diluted (in dollars per share) | $1.84 | $2.16 | $2.08 |
| Basic (in shares) | 206.0M shares | 173.6M shares | 172.2M shares |
| Diluted (in shares) | 209.2M shares | 178.2M shares | 177.3M shares |
Every line of the balance sheet in the latest annual report, as filed.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $134.9M | $117.4M | |
| Accounts receivable, net | $358.5M | $404.5M | |
| Inventories | $630.0M | $447.0M | |
| Prepaid expenses and other current assets | $170.7M | $96.5M | |
| Total Current Assets | $1.3B | $1.1B | |
| Restricted cash | $0 | $1.6B | |
| Property, plant and equipment, net | $1.0B | $811.1M | |
| Goodwill | $4.6B | $1.1B | $1.1B |
| Trade name and other intangible assets, net | $2.6B | $700.5M | |
| Operating lease right-of-use assets | $1.9B | $598.8M | |
| Deferred income taxes | $18.5M | $15.3M | |
| Other non-current assets | $207.1M | $130.3M | |
| Total Assets | $11.6B | $6.0B | |
| Accounts payable | $401.6M | $360.5M | |
| Accrued expenses and other current liabilities | $636.5M | $393.9M | |
| Short-term operating lease obligations | $399.6M | $126.8M | |
| Income taxes payable | $15.1M | $9.6M | |
| Current portion of long-term debt | $112.4M | $69.5M | |
| Total Current Liabilities | $1.6B | $960.3M | |
| Long-term debt, net | $4.6B | $3.7B | |
| Long-term operating lease obligations | $1.6B | $532.1M | |
| Deferred income taxes | $624.9M | $108.3M | |
| Other non-current liabilities | $130.6M | $71.0M | |
| Total Liabilities | $8.5B | $5.4B | |
| Redeemable non-controlling interest | $8.9M | $9.3M | $10.0M |
| Common stock, $0.01 par value, 500.0 million shares authorized; 283.8 million shares issued as of December 31, 2025 and 2024 | $2.8M | $2.8M | |
| Additional paid in capital | $1.0B | $501.2M | |
| Retained earnings | $3.8B | $3.6B | |
| Accumulated other comprehensive loss | -$98.4M | -$186.8M | |
| Treasury stock at cost; 73.9 million and 110.2 million shares as of December 31, 2025 and 2024, respectively | -$1.7B | -$3.3B | |
| Total Stockholders' Equity | $3.1B | $559.0M | $323.4M |
| Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity | $11.6B | $6.0B | |
| Common stock, par value per share (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 500.0M shares | 500.0M shares | |
| Common stock, shares issued (in shares) | 283.8M shares | 283.8M shares | |
| Treasury stock, shares (in shares) | 73.9M shares | 110.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income before non-controlling interest | $385.3M | $385.7M | $370.7M |
| Depreciation and amortization | $249.5M | $165.1M | $135.3M |
| Amortization of stock-based compensation | $41.0M | $36.4M | $47.7M |
| Amortization of deferred financing costs and discounts | $6.7M | $4.3M | $3.9M |
| Bad debt expense | $5.6M | $22.5M | $8.2M |
| Deferred income taxes | $25.8M | -$19.2M | $8.3M |
| Dividends received from unconsolidated affiliates | $20.5M | $24.3M | $20.4M |
| Equity income in earnings of unconsolidated affiliates | -$19.6M | -$18.9M | -$23.0M |
| Loss on disposal of business | $0 | $0 | $1.4M |
| Loss on disposal of business | $13.9M | $0 | $0 |
| Foreign currency adjustments and other | $16.9M | $1.7M | -$900.0K |
| Accounts receivable | $72.6M | -$7.3M | -$11.5M |
| Inventories | $136.5M | $26.8M | $75.8M |
| Prepaid expenses and other assets | -$18.9M | -$23.6M | $50.1M |
| Operating leases, net | $8.8M | $2.3M | $5.3M |
| Accounts payable | -$133.1M | $58.3M | -$46.9M |
| Accrued expenses and other liabilities | -$35.5M | -$21.1M | -$14.7M |
| Income taxes receivable and payable | $24.1M | $29.2M | -$59.8M |
| Net cash provided by operating activities | $800.1M | $666.5M | $570.3M |
| Purchases of property, plant and equipment | -$166.9M | -$97.3M | -$185.4M |
| Acquisitions, net of cash acquired | -$2.8B | $0 | -$3.0M |
| Purchases of investments | -$41.7M | $0 | $0 |
| Other | $8.8M | $600.0K | $600.0K |
| Net cash used in investing activities | -$3.0B | -$96.7M | -$187.8M |
| Proceeds from borrowings under long-term debt obligations | $4.4B | $3.0B | $2.7B |
| Repayments of borrowings under long-term debt obligations | -$3.5B | -$1.8B | -$2.9B |
| Proceeds from exercise of stock options | $49.5M | $500.0K | $2.9M |
| Treasury stock repurchased | -$132.4M | -$43.8M | -$36.0M |
| Dividends paid | -$127.4M | -$92.7M | -$77.7M |
| Payment of deferred financing costs | $0 | -$13.7M | -$6.5M |
| Repayments of finance lease obligations and other | -$22.6M | -$19.3M | -$16.2M |
| Net cash provided by (used in) financing activities | $616.9M | $1.1B | -$384.3M |
| NET EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | $32.5M | -$12.4M | $7.3M |
| (Decrease) increase in cash, cash equivalents and restricted cash | -$1.6B | $1.6B | $5.5M |
| Interest | $278.3M | $157.7M | $144.6M |
| Treasury stock issued in connection with Mattress Firm Acquisition | $2.2B | $0 | $0 |
Subsidiaries and ownership
Subsidiaries
- Sealy Corporation
- Tempur-Pedic
From Wikidata.1
Former names
Timeline
- 2012Founded Founded1
Recent filings
- Sep 8, 2026S-8 POS
- Sep 8, 2026S-8
- Aug 28, 20263
- Aug 28, 20264
- Aug 28, 20263
- Aug 28, 20264
- Aug 27, 20264
- Aug 26, 20268-K
- Aug 25, 20268-K 08.25.2026 FORM 8-K - MARKET UPDATE
- Aug 7, 202610-Q 10-Q 2026.06.30
- Aug 6, 20268-K
- Aug 6, 2026425
- Aug 6, 2026SCHEDULE 13G/A
- Aug 6, 2026POSASR
- Aug 6, 20268-K 08.06.2026 FORM 8-K INVESTOR PRESENTATION
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.tempursealy.com1
- WikipediaSomnigroup International
- WikidataQ19604577
- SEC EDGARCIK 1206264
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13